Advances in medicine are taking place by leaps and bounds and one of them is LIPOSCALE, a test that allows an exhaustive analysis of the lipid profile with a blood sample. Until now, the lipid profile was extracted from the information obtained in the analysis as a numerical value of total cholesterol (e.g. 230 mg/dl) and triglycerides (e.g. 210 mg/dl).
Although we have other specific fractions that determine the cardiovascular risk of individuals and we have been doing so, the truth is that LIPOSCALE is going to be a revolution in the field of Internal Medicine and Cardiovascular Risk.
What does LIPOSCALE involve?
Until now we could predict the residual risk, i.e. the probability that patients with cholesterol levels or cholesterol fractions in the normal range will suffer a cardiovascular event (myocardial infarction, stroke, etc.). This was possible through the results of conventional analytical tests which informed us of the cholesterol values in absolute numbers, but the LIPOSCALE test goes further and in addition to providing quantitative data also informs us of the quality (number and composition of the cholesterol particles) which can be decisive in reclassifying cardiovascular risk.
Of special interest is the application of the test in young patients with overweight/obesity and metabolic syndrome profile, since the qualitative characteristics of lipoproteins inform and contribute to classify individuals according to their real risk, promoting a therapeutic strategy as adjusted as possible to the patient’s needs.